Bioworld Financial Watch articles from December 2004

Bioworld Financial Watch archives from December 2004

Genta's antisense bid flops but others won't give up.(Research Still Worthy, Analysts Say)
December 6, 2004... After Genta Inc.'s third strike in a year with Genasense--which failed in a Phase III study last week against multiple myeloma, two weeks after a mixed outcome against leukemia that cost the company its deal with Aventis SA--investors are...

10 biggest U.S. gainers for the week.
December 6, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Biomira 135.97 Nektar Thera 4.78 Imcor 67.65 United Thera 3.46 Nanogen 52.81 ...

10 biggest U.S. losers for the week.
December 6, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Northwest BioThera -30.00 OSI Pharma -2.41 Ortec Int'l -26.45 Pharmion -1.59 Xcyte Therapies -20.71 ...

Public financing of biotechnology: November 2004.
December 6, 2004... Public Financing Of Biotechnology: November 2004 I. COMMENCED TRADING IN NOVEMBER Company Date Date Shares/ Price Shares Out (Symbol) (#) Filed Comm. Units (M) (M) (@) INITIAL...

Other financings of public biotechnology companies: November 2004.
December 6, 2004... Other Financings Of Public Biotechnology Companies: November 2004 TOTAL: $2,314.04M Company Type Of Number Of Amount (Symbol) (#) Financing Shares, Units Raised ...

Venture capital and corporate investment in biotechnology companies: November 2004.
December 6, 2004... Venture Capital And Corporate Investments In Biotechnology Companies: November 2004 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $379.7M Company Location Date Amt. (M) BioMimetic ...

Money raised by biotech in 2004: January-November.
December 6, 2004... Money Raised By Biotech In 2004: January-November Type of Jan. Feb. Mar. Apr. financing Public offerings 352.1 997.8 586.6 518.2 Private biotechs 444.3 367.0...

BioWorld stock report for public biotechnology companies.
December 6, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change Vol 11/24 12/3 WK YTD (000) Aastrom Biosci ASTM 0.98...

Hectorol good to bone, as well as BCI's bottom line.
December 13, 2004... Drink your milk. That parental edict, heard less often in recent years, had as much to do with the hectored youngster's need for vitamin D (with which the disliked cow juice was enriched), as with the importance of calcium for bone...

10 biggest U.S. gainers for the week.
December 13, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Genta 43.48 CoTherix 36.34 Columbia Labs 35.71 Genelabs 26.76 Alteon 26.74 Discovery Labs 25.25 Allos ...

10 biggest U.S. losers for the week.
December 13, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Corgentech -58.95 Biopure -30.23 Biomira -23.48 Maxim Pharma -21.01 Praecis -19.82 V.I. Technol -19.70 Deltagen ...

Clinical trials update: November 2004.
December 13, 2004... Clinical Trials Update: November 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Berlex Inc. Betaseron Interferon beta-1b (unit of (FDA-approved) Schering AG)...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: November 2004.
December 13, 2004... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: November 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Active Biotech 57-57 Product...

FDA submissions, approvals and other actions: November 2004.
December 13, 2004... FDA Submissions, Approvals And Other Actions: November 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Biogen Idec Tysabri Natalizumab; humanized Inc. (BIIB) and ...

BioWorld stock report for public biotechnology companies.
December 13, 2004... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 12/3 12/10 ...

Opinions differ on what's ahead in CMS changes.
December 20, 2004... "Happy new year" might not be the way, exactly, to describe the sort of 2005 that oncologists--not to mention their patients--might expect as a result of changes wrought by the Medicare Modernization Act. How unhappy the year might be...

10 biggest U.S. gainers for the week.
December 20, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Imcor 62.50 OSI Pharma 21.41 OSI Pharma 45.58 Sepracor 8.00 Alteon 44.04 ImClone Sys ...

10 biggest U.S. losers for the week.
December 20, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) CoTherix -17.24 CoTherix -1.85 Aphton -16.84 Celgene -1.83 Genta -15.15 Flamel Tech ...

Biotech-big pharma collaborations: new agreements, Oct. 21-Dec. 15, 2004#.
December 20, 2004... Biotech-Big Pharma Collaborations: New Agreements, Oct. 21 - Dec. 15, 2004 (#) Biotech Co. * Pharma Co. Type/Product Area (Country; Symbol) (Country) airPharma * Britannia airPharma will develop...

Manufacturing, marketing and distribution agreements between biotech and pharmaceuticals companies: Oct. 21-Dec. 15, 2004#.
December 20, 2004... Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Oct. 21 - Dec. 15, 2004 (#) Biotech Co. * Pharma Co. Product (Country; Symbol) (Country) Advancis Ceph...

Biotech-big pharma collaborations: modified and terminated agreements, Oct. 21-Dec. 15, 2004#.
December 20, 2004... Biotech-Big Pharma Collaborations: Modified And Terminated Agreements, Oct. 21 - Dec. 15, 2004 (#) Biotech Co. * Pharma Co. Change from original (Country; Symbol) (Country) agreement I. MODIFIED AGREEMENTS...

BioWorld stock report for public biotechnology companies.
December 20, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 12/10 12/17 Aastrom Biosci ASTM 1.11 1.14 Abgenix ...

'Targeted' cancer drugs' future might depend on diagnostics.(Does New Research Explain Iressa Failure?)
December 27, 2004... The near-term meaning of this month's blowup of AstraZeneca plc's Iressa, the epidermal growth factor inhibitor against non-small-cell lung cancer, was clear--a strong boost for Genentech Inc. and OSI Pharmaceuticals Inc., whose EGFR drug,...

10 biggest U.S. gainers for the week.
December 27, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Immucell 80.47 Northwest BioThera 71.43 Cygnus 66.67 Genelabs 47.25 Avax Technol 30.43 CollaGenex 26.51 Biopure ...

10 biggest U.S. losers for the week.
December 27, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Pharmos -68.86 Adolor -44.25 Alteon -24.20 Inhibitex -21.90 La Jolla Pharma -21.57 Alliance -20.00 MannKind ...

Grants, contracts and awards to Biotech companies: Oct. 1-Dec. 21, 2004.
December 27, 2004... Grants, Contracts And Awards To Biotech Companies: Oct. 1-Dec. 21, 2004 Company * Funding Amount (Country; Symbol) Institution (M) Active Pass National Institute ...

BioWorld stock report for public biotechnology companies.
December 27, 2004... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 12/17 12/23 ...